Sofosbuvir–daclatasvir was non-inferior to sofosbuvir–velpatasvir. High efficacy was seen with novel strategies, which might help to inform approaches to treatment for harder-to-reach populations.

Lack of incentives is driving down the number of clinical researchers in Britain

A life dedicated to understanding viruses with pandemic potential

The British scientist on the risk of humans contracting bird flu, how people would cope with new lockdowns and being asked to pour the tea because she is a woman

New research underscores the need for ongoing COVID-19 protection for people with weakened immune systems.

The Royal Institute of British Architects (RIBA) has announced the architect selected to design the inaugural Fleming Centre.

Professor Anthony Harnden has officially started his role as Chair of the Medicines and Healthcare products Regulatory Agency (MHRA).